Effect of ethanol in paclitaxel injections on the ethanol concentration in exhaled breath

Tohru Aomori, Hironori Makino, Masayuki Sekizuka, Tadahiro Hashita, Takuya Araki, Keiko Iizuka, Tomonori Nakamura, Koujirou Yamamoto

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Ethanol is included in certain injectable preparations of anticancer drugs to increase their solubility. Since the volume of ethanol in these preparations is approximately half of the total injection volume, the potential inhibitory effects of ethanol on the central nervous system cannot be disregarded, especially considering that patients may drive immediately after administration of the medication. Therefore, the concentration of ethanol was examined in exhaled breath after administration of paclitaxel, an anticancer medication containing ethanol. Methods: The ethanol concentration in exhaled breath immediately after an intravenous infusion of paclitaxel was measured in 30 patients, using a balloon- type gas detector tube. Correlations between the concentration of ethanol in exhaled breath and the total amount of ethanol administered or the intravenous infusion speed were calculated. Results: The mean ethanol concentration in exhaled breath was 0.028 - 0.015 mg/L. The correlation between the ethanol concentration in exhaled breath and the total dose of ethanol was weak (R2 = 0.25; p = 0.055), while the intravenous infusion speed showed a stronger positive correlation with the concentration of ethanol in the breath (R2 = 0.49; p = 0.11). The maximum concentration of ethanol measured in exhaled breath (0.06 mg/L) was equivalent to 40% of the threshold for drunk driving, as specified in the Road Traffic Act in Japan. Conclusion: In this study, no patient had a breath ethanol concentration exceeding the legal threshold for drunk driving. However, it is still advisable for patients to avoid driving after receiving paclitaxel injections. When driving cannot be avoided, patients should wait for a sufficient time after receiving the injection before driving. Adis

Original languageEnglish
Pages (from-to)165-170
Number of pages6
JournalDrugs in R and D
Volume12
Issue number3
DOIs
Publication statusPublished - 2012
Externally publishedYes

Fingerprint

Paclitaxel
Ethanol
Injections
Intravenous Infusions
Drug Compounding
Solubility
Japan
Central Nervous System
Gases

Keywords

  • Alcohol
  • Driving
  • Infusion
  • Intravenous
  • Paclitaxel.

ASJC Scopus subject areas

  • Pharmacology

Cite this

Aomori, T., Makino, H., Sekizuka, M., Hashita, T., Araki, T., Iizuka, K., ... Yamamoto, K. (2012). Effect of ethanol in paclitaxel injections on the ethanol concentration in exhaled breath. Drugs in R and D, 12(3), 165-170. https://doi.org/10.2165/11634690-000000000-00000

Effect of ethanol in paclitaxel injections on the ethanol concentration in exhaled breath. / Aomori, Tohru; Makino, Hironori; Sekizuka, Masayuki; Hashita, Tadahiro; Araki, Takuya; Iizuka, Keiko; Nakamura, Tomonori; Yamamoto, Koujirou.

In: Drugs in R and D, Vol. 12, No. 3, 2012, p. 165-170.

Research output: Contribution to journalArticle

Aomori, Tohru ; Makino, Hironori ; Sekizuka, Masayuki ; Hashita, Tadahiro ; Araki, Takuya ; Iizuka, Keiko ; Nakamura, Tomonori ; Yamamoto, Koujirou. / Effect of ethanol in paclitaxel injections on the ethanol concentration in exhaled breath. In: Drugs in R and D. 2012 ; Vol. 12, No. 3. pp. 165-170.
@article{e4570df840e841b28a06dec9b9fa37a0,
title = "Effect of ethanol in paclitaxel injections on the ethanol concentration in exhaled breath",
abstract = "Background: Ethanol is included in certain injectable preparations of anticancer drugs to increase their solubility. Since the volume of ethanol in these preparations is approximately half of the total injection volume, the potential inhibitory effects of ethanol on the central nervous system cannot be disregarded, especially considering that patients may drive immediately after administration of the medication. Therefore, the concentration of ethanol was examined in exhaled breath after administration of paclitaxel, an anticancer medication containing ethanol. Methods: The ethanol concentration in exhaled breath immediately after an intravenous infusion of paclitaxel was measured in 30 patients, using a balloon- type gas detector tube. Correlations between the concentration of ethanol in exhaled breath and the total amount of ethanol administered or the intravenous infusion speed were calculated. Results: The mean ethanol concentration in exhaled breath was 0.028 - 0.015 mg/L. The correlation between the ethanol concentration in exhaled breath and the total dose of ethanol was weak (R2 = 0.25; p = 0.055), while the intravenous infusion speed showed a stronger positive correlation with the concentration of ethanol in the breath (R2 = 0.49; p = 0.11). The maximum concentration of ethanol measured in exhaled breath (0.06 mg/L) was equivalent to 40{\%} of the threshold for drunk driving, as specified in the Road Traffic Act in Japan. Conclusion: In this study, no patient had a breath ethanol concentration exceeding the legal threshold for drunk driving. However, it is still advisable for patients to avoid driving after receiving paclitaxel injections. When driving cannot be avoided, patients should wait for a sufficient time after receiving the injection before driving. Adis",
keywords = "Alcohol, Driving, Infusion, Intravenous, Paclitaxel.",
author = "Tohru Aomori and Hironori Makino and Masayuki Sekizuka and Tadahiro Hashita and Takuya Araki and Keiko Iizuka and Tomonori Nakamura and Koujirou Yamamoto",
year = "2012",
doi = "10.2165/11634690-000000000-00000",
language = "English",
volume = "12",
pages = "165--170",
journal = "Drugs in R&D",
issn = "1174-5886",
publisher = "Adis International Ltd",
number = "3",

}

TY - JOUR

T1 - Effect of ethanol in paclitaxel injections on the ethanol concentration in exhaled breath

AU - Aomori, Tohru

AU - Makino, Hironori

AU - Sekizuka, Masayuki

AU - Hashita, Tadahiro

AU - Araki, Takuya

AU - Iizuka, Keiko

AU - Nakamura, Tomonori

AU - Yamamoto, Koujirou

PY - 2012

Y1 - 2012

N2 - Background: Ethanol is included in certain injectable preparations of anticancer drugs to increase their solubility. Since the volume of ethanol in these preparations is approximately half of the total injection volume, the potential inhibitory effects of ethanol on the central nervous system cannot be disregarded, especially considering that patients may drive immediately after administration of the medication. Therefore, the concentration of ethanol was examined in exhaled breath after administration of paclitaxel, an anticancer medication containing ethanol. Methods: The ethanol concentration in exhaled breath immediately after an intravenous infusion of paclitaxel was measured in 30 patients, using a balloon- type gas detector tube. Correlations between the concentration of ethanol in exhaled breath and the total amount of ethanol administered or the intravenous infusion speed were calculated. Results: The mean ethanol concentration in exhaled breath was 0.028 - 0.015 mg/L. The correlation between the ethanol concentration in exhaled breath and the total dose of ethanol was weak (R2 = 0.25; p = 0.055), while the intravenous infusion speed showed a stronger positive correlation with the concentration of ethanol in the breath (R2 = 0.49; p = 0.11). The maximum concentration of ethanol measured in exhaled breath (0.06 mg/L) was equivalent to 40% of the threshold for drunk driving, as specified in the Road Traffic Act in Japan. Conclusion: In this study, no patient had a breath ethanol concentration exceeding the legal threshold for drunk driving. However, it is still advisable for patients to avoid driving after receiving paclitaxel injections. When driving cannot be avoided, patients should wait for a sufficient time after receiving the injection before driving. Adis

AB - Background: Ethanol is included in certain injectable preparations of anticancer drugs to increase their solubility. Since the volume of ethanol in these preparations is approximately half of the total injection volume, the potential inhibitory effects of ethanol on the central nervous system cannot be disregarded, especially considering that patients may drive immediately after administration of the medication. Therefore, the concentration of ethanol was examined in exhaled breath after administration of paclitaxel, an anticancer medication containing ethanol. Methods: The ethanol concentration in exhaled breath immediately after an intravenous infusion of paclitaxel was measured in 30 patients, using a balloon- type gas detector tube. Correlations between the concentration of ethanol in exhaled breath and the total amount of ethanol administered or the intravenous infusion speed were calculated. Results: The mean ethanol concentration in exhaled breath was 0.028 - 0.015 mg/L. The correlation between the ethanol concentration in exhaled breath and the total dose of ethanol was weak (R2 = 0.25; p = 0.055), while the intravenous infusion speed showed a stronger positive correlation with the concentration of ethanol in the breath (R2 = 0.49; p = 0.11). The maximum concentration of ethanol measured in exhaled breath (0.06 mg/L) was equivalent to 40% of the threshold for drunk driving, as specified in the Road Traffic Act in Japan. Conclusion: In this study, no patient had a breath ethanol concentration exceeding the legal threshold for drunk driving. However, it is still advisable for patients to avoid driving after receiving paclitaxel injections. When driving cannot be avoided, patients should wait for a sufficient time after receiving the injection before driving. Adis

KW - Alcohol

KW - Driving

KW - Infusion

KW - Intravenous

KW - Paclitaxel.

UR - http://www.scopus.com/inward/record.url?scp=84865855693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865855693&partnerID=8YFLogxK

U2 - 10.2165/11634690-000000000-00000

DO - 10.2165/11634690-000000000-00000

M3 - Article

VL - 12

SP - 165

EP - 170

JO - Drugs in R&D

JF - Drugs in R&D

SN - 1174-5886

IS - 3

ER -